Mutations in genes in the mTOR pathway, such as KRAS, epidermal growth factor receptor (EGFR), LKB1, PTEN, PIK3CA, AKT1, EGFR, PIK3CA, and PTEN, have some relationship with the development of NSCLC (29). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.